After a lengthy battle for access, Selexipag was approved as a treatment for pulmonary hypertension across the UK in April 2019. We caught up with Neil Hamilton, consultant pharmacist at the Sheffield Pulmonary Vascular Disease Unit, to sort the fact from the fiction.
Nearly all PH patients in the UK benefit from homecare delivery – where medication is brought to your home. Why do you receive it that way and what are the benefits? Consultant pharmacist Neil Hamilton explains.
We are appreciative to Actelion Pharmaceuticals UK Ltd for an unrestricted grant to support the structure of this website. Actelion Pharmaceuticals Ltd have had no input into the contents of the website, which remains copyright to the PHA UK.